← All trials
NCT03725618
Phase 4Interventional
Studies of FDA-approved drugs to delineate additional information including the drug's risks, benefits, and optimal use.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Nov 30, 2018
- Primary completion
- Sep 30, 2019
- Completion date
- Sep 30, 2020
- First posted
- —
- Last posted
- —
- Enrollment
- 1788
- Arms / groups
- 3 / —
- Source
- AACT · ingestion pipeline
Sponsors
- Centers for Disease Control and Prevention (CDC)Lead sponsor
- Medical Research Council-UVRI Uganda Research Unit on AIDSCollaborator
- Infectious Disease Institute, Kampala, UgandaCollaborator
- Government of UgandaCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.